Has Manpreet Singh, MD received payments from drug or device companies?

Yes. Drug and device makers reported $568 in general payments to Manpreet Singh, MD across 9 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Manpreet Singh, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Manpreet Singh, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Manpreet Singh, MD

Nephrology · Harrisburg, PANPI 1629238993

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Amgen at 23.4% of the total. 2025 is the largest year on record at $160, more than ten times the $11 reported in 2019. That places this record below the midpoint for nephrology clinicians in PA, where the typical reported total is $612.

$568in general payments, 2019–2025

Across 9 payments — averaging $63.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$133
AstraZeneca$125
Travere Therapeutics, Inc.$123
Philips North America LLC$113
Biogen$48
Vifor Pharma, Inc.$14
plus $11 from 1 others

$124,118in research payments, 2019–2025

Across 267 payments — averaging $464.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

CSL Behring$123K
H. Lundbeck A S$669

What the payments were for

Food & beverage$568100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	2	$133
AstraZeneca	1	$125
Travere Therapeutics, Inc.	1	$123
Philips North America LLC	1	$113
Biogen	2	$48
Vifor Pharma, Inc.	1	$14
Mallinckrodt Enterprises LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Tavneos$117
(9520) IGT Devices Undivided$113

How this compares

$568 in reported general payments places this provider in the 45th percentile of 586 nephrology providers in Pennsylvania.

See all nephrology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$34,432

Medicare patients

213

Services billed

363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cinacalcet Hcl	54	$27,436
Fosfomycin Tromethamine	37	$20,475
Mycophenolic AcidMycophenolate Sodium	36	$14,652
EliquisApixaban	11	$7,178
Tacrolimus	60	$6,804
Valganciclovir Hcl	18	$6,641
Entecavir	13	$2,568
Potassium Chloride	51	$2,234
Tamsulosin Hcl	216	$1,680
Mycophenolate Mofetil	14	$1,406
Metoprolol Succinate	76	$1,227
Methenamine Hippurate	23	$1,176
Pantoprazole Sodium	127	$1,124
Bumetanide	33	$1,124
Prednisone	214	$945

Paid to pharmacies, not to this prescriber.

Other nephrology in Harrisburg

Jonathan DiamondHarrisburg$249K
Nelson KopytAllentown$949K
Christopher GislerPittsburgh$757K
Rakesh GulatiPhiladelphia$657K
Raymond TownsendPhiladelphia$357K
Prince AnandDanville$331K
Ellie KelepourisPhiladelphia$287K
Abdallahsassine GearaPhiladelphia$225K
Khaled NasharPittsburgh$198K
Katalin SusztakPhiladelphia$192K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →